NCT00056264View on ClinicalTrials.gov

A Study of Safety and Efficacy of Infliximab (Remicade) in Patients With COPD

PHASE3CompletedINTERVENTIONAL
Enrollment

234

Participants

Timeline

Start Date

December 31, 2002

Study Completion Date

December 31, 2004

Conditions
Chronic Obstructive Pulmonary DiseaseCOPD
Interventions
DRUG

Infliximab

Sponsors

Lead Sponsor

Centocor, Inc.
All Listed Sponsors
lead

Centocor, Inc.

INDUSTRY